GJA1 and pancreatic neoplasm: In one study on pancreatic cancer cells, SFN treatment inhibited miR-30a-3p expression, which was shown to target Cx43 and increase its expression, which led to better gemcitabine chemosensitivity (Georgikou et al., 2020).